Abstract
Parathyroid hormone (PTH) may cause bone rarefaction by mobilization of Ca, but its role in osteoporosis has not been fully established. The majority of patients with osteoporosis have normal serum levels of PTH, but, histomorphometric evaluation of bone biopsies suggests the presence of hyperparathyroidism in senile osteoporosis. Postsurgical hypoparathyrodism, on the other hand, results in elevation of bone densitometry preventing the age-related loss of bone mass.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
